N

Neko Health

Runs preventive-health clinics with scans

Senior Research Sonographer

Full-Time
No salary listed
Senior
Master's
Birmingham, UK
In Person
Medical, Clinical & VeterinaryDiagnostics & Laboratory Professionals

About the job

Requirements
  • HCPC registration as a diagnostic radiographer, or registration as another HCPC- or NMC-registered healthcare professional.
  • A CASE-accredited postgraduate qualification in breast ultrasound, such as a PgCert, PgDip, MSc, or a named CASE-accredited breast ultrasound module.
  • Current documented breast ultrasound practice with at least two years of full-time-equivalent breast scanning experience.
  • Advanced radiographic reporting experience performed autonomously within the NHS Breast Screening Programme or an equivalent quality-assurance framework.
  • Ability to explain complex information clearly to study participants.
  • Commitment to maintaining high clinical standards and engaging in ongoing professional development.
Responsibilities
  • Perform diagnostic ultrasound examinations in line with clinical guidelines and best practices, with a focus on breast ultrasound.
  • Complete the study-specific acquisition and interpretation qualification task before performing study scans, with the certificate filed in the investigational site file.
  • Independently interpret and report ultrasound findings and upload results promptly to a standardised electronic case report form.
  • Collaborate with the multidisciplinary research team to deliver the clinical trial focused on understanding breast cancer risks.
  • Adhere to the study acquisition standard operating procedure.
  • Maintain equipment quality assurance records on-site and liaise with the study principal investigator and research team as needed.
Desired Qualifications
  • Previous experience performing ultrasound scanning as part of clinical trials.
  • Experience acquiring and reporting shear-wave elastography.
  • Experience using Philips ultrasound machines and decision-support software.
  • Familiarity with data entry for clinical research studies.

About the company

Draft a concise company summary for Neko Health based on provided details: It is a preventive health company with clinics and proprietary scanning hardware offering a ~60-minute non-invasive full-body assessment including skin imaging, biomarkers, blood analysis and clinician consultation; operates in Sweden and UK with expansion to US; raised significant funding; goal to expand clinics and health-data/hardware platform.

Company Size

501-1,000

Company Stage

N/A

Total Funding

$1.2B

Headquarters

Stockholms kommun, Sweden

Founded

2018

Get referred to Neko Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • New York opened September 24, 2026, with 25,000 waitlisted before launch.
  • Neko raised $700 million in July 2026, funding U.S. clinics and hiring.
  • Over 100,000 scans and 80% third-scan rebooking show strong retention and recurring demand.

What critics are saying

  • Function Health's $450 million financing and 300,000-plus members compress Neko's U.S. growth window.
  • Prenuvo's 21 U.S. clinics and MRI depth steal higher-risk customers needing organ imaging.
  • If clinical outcomes stay unproven, Neko becomes a luxury wellness brand, not healthcare.

What makes Neko Health unique

  • Daniel Ek and Hjalmar Nilsonne built proprietary scan hardware, software, and clinics in-house.
  • Neko combines skin imaging, cardiovascular sensors, biomarkers, and clinician review in one visit.
  • FDA cleared Spectrum-2 and Derma-2 in 2026, strengthening its regulated-device credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

6%

2 year growth

0%
AndroGuider
Oct 1st, 2026
Neko Health's $700M US launch: is daniel Ek's body scan worth it.

Neko Health's $700M US launch: is daniel Ek's body scan worth it. Tl;dr. * Neko Health has officially launched in the US after a massive $700 million raise, pushing its valuation past $4 billion and funding flagship clinics in New York and the Bay Area. * For $1,095, members get a 60-minute, AI-powered full-body scan that maps skin, heart, metabolism and blood biomarkers, with results delivered in-app in under an hour. * Investors are betting preventative care is the next trillion-dollar category, but Neko faces stiff competition from Function Health's $499 lab-first model and Prenuvo-style MRI scanners, plus questions about FDA clearance and real clinical value. The Spotify playbook, but for your body. Daniel Ek conquered music with Spotify. Now he wants to conquer healthcare. Neko Health, the Swedish preventative health startup Ek co-founded with Hjalmar Nilsonne in 2018, has officially arrived in America. The company confirmed this month it has closed a $700 million Series C to scale across the US, opening its first American flagship in Manhattan's SoHo, with San Francisco and Boston slated for early 2027. It's one of the largest health-tech raises of the year, led by Lightspeed Venture Partners with participation from Atomico, General Catalyst, and Ek's own family office. The round values Neko at over $4 billion, making it Europe's most valuable longevity startup by far. The pitch is simple and seductive: for people tired of 7-minute doctor visits and reactive sick-care, Neko offers a fast, futuristic, full-body checkup that finds problems before symptoms appear. Americans are clearly curious. Neko says more than 200,000 people joined its US waitlist before launch, echoing the frenzy it saw in Stockholm and London where appointments sold out for months. How Neko's body scan actually works. Walk into Neko's SoHo clinic and it doesn't feel like a doctor's office. It feels like an Apple Store crossed with a spaceship. The core experience is a 60-minute, non-invasive scan in what Neko calls the Body Pod. Here's the breakdown: First, a high-resolution 3D body mapping system takes thousands of images of your skin, tracking every mole, freckle, and lesion down to 0.2mm. AI flags changes that could signal melanoma or other skin conditions. Second, you lie back for cardiovascular screening. Neko uses non-contact sensors, blood pressure mapping, ECG, and ultrasound-like blood flow measurements to assess arterial stiffness, heart function, and circulation - key early markers for stroke and heart disease. Third is the blood draw. Unlike a standard annual physical that tests 10-15 markers, Neko runs 100+ biomarkers covering cholesterol, blood sugar, inflammation, kidney and liver function, thyroid, and metabolic syndrome risk. All of that data is fused by Neko's AI engine and reviewed by a licensed physician on-site. Within an hour, your results pop up in the Neko app with a Health Score, trend lines, and a face-to-face consultation to go over red flags. No gowns in cold hallways. No waiting three weeks for lab results. No MRI tube. In the US, the full scan costs $1,095 out-of-pocket, with annual re-scans at $695 for members. Insurance doesn't cover it - at least not yet. Neko vs. Function Health vs. Prenuvo and the Midjourney crowd. Neko isn't entering an empty market. Longevity is suddenly Silicon Valley's hottest battleground. Function Health, co-founded by Levels founder Sam Corcos and backed by Andreessen Horowitz, is Neko's closest rival. At $499 per year, Function skips the fancy clinic and goes lab-first: 160+ blood tests, twice a year, with insights from top doctors including Mark Hyman. It's cheaper and already has 300,000+ paying members in the US, but there's no in-person 3D body scan or cardiac imaging. On the high end is Prenuvo, the $2,500 whole-body MRI darling of Kim Kardashian and Ashton Kutcher. Prenuvo gives you a stunningly detailed look inside - tumors, cysts, spine and brain anomalies - in a 60-minute MRI. It's powerful, but slow, expensive, and prone to incidental findings that cause anxiety. Neko argues its approach is faster, more affordable, and better for yearly tracking. Then there's the wild card: the AI-imaging wave coming from Midjourney circles. Midjourney founder David Holz has been teasing a separate AI health-scanning research project focused on low-cost, vision-model diagnostics, and a host of startups inspired by that work are promising iPhone-based skin and posture scans for under $100. They're nowhere near Neko's clinical depth, but they show where the tech is headed - preventative screening as cheap and ubiquitous as a selfie. In short: Function wins on price and labs, Prenuvo wins on deep imaging, Neko is trying to win on experience - a one-stop, design-forward middle ground. Why Investors just bet $700 million on longevity. Why would VCs pour $700 million into physical clinics, one of the hardest businesses to scale? Three reasons. One, the economics of prevention are flipping. Chronic disease costs the US $4.5 trillion a year. Employers and wealthy consumers will happily pay $1,000 a year if it catches diabetes, heart disease, or skin cancer early. Neko already claims profitability per clinic in Sweden, with 80% of members rebooking. Two, AI finally makes it scalable. Neko says its models, trained on millions of scans from Stockholm, London, and now New York, cut doctor review time by 70%. That means one physician can supervise far more patients than in traditional primary care. Three, data is the moat. Every scan makes Neko's risk-prediction engine smarter. Investors aren't just buying clinic revenue - they're buying what could become the largest private dataset of preventative human health in the world. Think Spotify's Wrapped, but for your arteries. Lightspeed partner Bejul Somaia called it "the first consumer health brand with Apple-level love and pharma-level rigor." Is it worth it? What doctors say. So, should you book? Early reviews from London and Stockholm are glowing on experience - 4.8 stars, spotless clinics, zero waiting. Users love seeing their own vascular age, skin map, and metabolic trends visualized beautifully. Doctors are more split. Supporters say Neko is exactly what modern medicine is missing: accessible baseline data, early detection, and patient empowerment. Catching high blood pressure at 32 or pre-diabetes at 38 can add a decade to your life. Skeptics warn of three issues. First, Neko's US offering is not FDA-cleared as a diagnostic device - it operates as a wellness screening service with physician oversight, which limits what it can officially claim to detect. Second, more data isn't always better. Broad biomarker testing can trigger false positives, unnecessary follow-ups, and anxiety. Third, $1,095 still prices out most Americans who need preventative care most. Neko counters that it refers less than 8% of members for urgent follow-up, partners with local health systems for referrals, and publishes its clinical validation studies openly. What's next for Neko in America. The $700 million won't sit still. Neko says 70% will go to US expansion: 10-15 clinics in major metros by 2028, a US-based AI research lab, and hiring 200+ physicians, nurses, and engineers. Longer term, Ek has hinted at at-home sensors, continuous glucose and blood pressure integration, and employer partnerships that could drop the price below $500. Whether Neko becomes the Spotify of healthcare or another luxury wellness fad for the worried well depends on one thing: can it prove its scans actually make people live longer, healthier lives - not just feel cooler about their health? For now, America's longevity gold rush has a sleek new Scandinavian flagship. And a 200,000-person waitlist suggests plenty of people are willing to pay to find out. AndroGuider Team Articles written by the AndroGuider team. Androguider try to make them thorough and informational while being easy to read.

BusinessCloud
Sep 25th, 2026
'Built in the UK': Neko Health opens in New York after $700m raise.

'Built in the UK': Neko Health opens in New York after $700m raise. Ground-breaking firm co-founded by Spotify's Daniel Ek has completed more than 100,000 60-minute scans - capturing millions of data points A ground-breaking HealthTech co-founded by Spotify's Daniel Ek which built its model in the UK has launched in New York. Ek founded Neko Health with Hjalmar Nilsonne to redefine how people understand and act on their health. This summer it raised $700 million in Series C funding. At the heart of Neko's offering is the Neko Health Scan - a 60-minute, comprehensive, non-invasive and radiation-free health assessment that captures millions of health data points. Neko has opened its first US clinic in SoHo, New York - the first step in a US roll-out, with more New York sites and Miami, Washington, DC and San Francisco also planned. The firm said there was a New York waitlist of more than 25,000 before opening day. More than 350,000 people have joined the waitlist or registered for a Neko Health Scan, and more than 100,000 in the UK and Sweden have already experienced one. The firm has added clinics in Manchester and Birmingham, as well as multiple locations in London. Priced at £299 in the UK and 2,750 SEK in Sweden, the scan uses proprietary sensors alongside blood analysis to assess skin health, including moles and marks; biomarkers to identify pre-diabetes risk; blood abnormalities; and risk factors linked to metabolic syndrome, stroke and heart attack. Results are delivered on-site within minutes and discussed during an in-person consultation with a medical professional, providing members with personalised and actionable health findings. In addition, body composition measures, captured in seconds during the scan, and clinician review of wearable data, is now live across all clinics - giving members an even more detailed picture of their health both in the moment and between visits. All Neko Health's technology has been built in-house, including hardware, software and consumer experience. Nilsonne previously co-founded and served as CEO of Watty, an energy data company which was acquired by Assa Abloy. He was raised in a family of doctors. As for the US, Neko says six in 10 American adults live with a chronic disease, and four in ten live with two or more. Roughly 90% of national health spending goes toward people managing chronic and mental health conditions. And yet, up to 80% of premature heart disease and stroke is preventable. "Hjalmar and I have talked about bringing Neko to America since the earliest days of the company because if you want to change healthcare at scale, the US has to be part of that ambition," said Ek. "New York is the starting point. New Yorkers place an incredible value on their time and have exceptionally high expectations for how they spend it. This city doesn't settle for good enough, and neither do we." In New York, Neko refers members who need additional care to vetted physicians and healthcare systems, including General Medicine, Columbia University Irving Medical Center (CUIMC), Schweiger Dermatology, and Mount Sinai Health System. "There's no better time than now to bring Neko Health to America," said CEO Nilsonne. "We've scanned more than 100,000 people across Sweden and the UK, and what we've seen is unmistakable: when people can see their health clearly and know what to do about it, they get healthier."

Vialynx Inc
Sep 24th, 2026
Neko Health opens its doors in NEW YORK, bringing the most valuable hour in healthcare to America.

Neko Health opens its doors in NEW YORK, bringing the most valuable hour in healthcare to America. Science · SEP 24, 2026 PR Newswire Booking begins today at Neko's first U.S. clinic in SoHo, where breakthrough technology and prevention-focused clinicians give members the bigger picture o... Booking begins today at Neko's first U.S. clinic in SoHo, where breakthrough technology and prevention-focused clinicians give members the bigger picture of their health in a single hour NEW YORK, Sept. 24, 2026 /PRNewswire/ - Today marks the opening day for Neko Health in the United States, after more than 25,000 New Yorkers joined the waitlist ahead of launch. Their clinic at 300 Lafayette Street in SoHo - the first of many planned across NYC and across the country - brings Neko's Scandinavian high-tech and high-touch experience to life. Across Sweden and the UK, more than 100,000 members have already experienced the Neko Health Scan. At the end of their first appointment, 75% of members book and prepay for their next scan, and after their second appointment, 80% of members book their third scan. The Neko Health Scan is the most valuable hour you can spend on your health. Hjalmar Nilsonne and Daniel Ek (Spotify) founded Neko Health to deliver preventive healthcare at scale, shifting the focus from treating disease after it develops to helping people understand and act on their health earlier. Neko engineered its technology and clinical experience entirely from the ground up. In one hour, you'll have a connected view of your skin, heart, blood, and metabolic health, all explained by a clinician before you leave. All of this for $499. The stakes are real: six in ten American adults live with a chronic disease, and four in ten live with two or more,[1] and roughly 90% of national health spending goes toward people managing chronic and mental health conditions.[1] And yet, up to 80% of premature heart disease and stroke is preventable.[2] "Hjalmar and I have talked about bringing Neko to America since the earliest days of the company because if you want to change healthcare at scale, the U.S. has to be part of that ambition," said Daniel Ek, Co-Founder of Neko Health. "New York is the starting point. New Yorkers place an incredible value on their time and have exceptionally high expectations for how they spend it. This city doesn't settle for good enough, and neither do we." The 60-minute, radiation-free visit combines the best of human, hardware, and health intelligence: a 360-degree skin exam with 6,000 images captured via a combination of cameras in the visual spectrum as well as thermal cameras, a cardiovascular assessment, detailed body composition analysis, on-site blood testing focused on 50+ essential biomarkers, and unrushed time with a clinician to walk through results and build a plan of action. The Neko Health Scan takes roughly 30 minutes, followed by a further 30 minutes with a clinician. Together, this creates a detailed baseline that can be tracked over time and helps surface early signals before symptoms appear, often while there's still time to act. After the appointment, members can access their results anytime through the Neko Health app on iOS and Android, which stores scan history, tracks changes over time, and syncs daily data from wearables like Oura or Whoop via Apple Health. The company designed and developed its own medical devices, hardware, software and systems to capture, analyze and present health data within a single experience. This allows Neko to ensure high quality, all while rapidly improving the technology, experience, and outcomes for members. "There's no better time than now to bring Neko Health to America," said Hjalmar Nilsonne, CEO and Co-Founder of Neko Health. "We've scanned more than 100,000 people across Sweden and the UK, and what we've seen is unmistakable: when people can see their health clearly and know what to do about it, they get healthier." In New York, Neko refers members who need additional care to vetted physicians and healthcare systems, including General Medicine, Columbia University Irving Medical Center (CUIMC), Schweiger Dermatology, and Mount Sinai Health System. This allows members to be connected quickly with high-quality, trusted clinicians when follow-up is needed, so they can move forward with confidence in the continuity of their care. Members can also be referred to their own clinicians, if they prefer. Neko also accepts HSA and FSA payment, making the experience more accessible to New Yorkers already setting aside pre-tax dollars for their health. The New York opening follows Neko Health's $700 million Series C, led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from Maria Sharapova, Zoe Saldaña, Mark Zuckerberg and Priscilla Chan, Danny Meyer, Claudia Schiffer and Sir Matthew Vaughn, Thierry Henry, Tim Ferriss and will.i.am. New York marks the first step in Neko Health's U.S. expansion. Additional New York locations and a Miami clinic are expected to follow, with Washington, D.C. and San Francisco also planned. Press kit link for imagery. About Neko Health Neko Health is a health technology company that opened its first clinic in Stockholm in 2023, founded by Daniel Ek and Hjalmar Nilsonne. Neko designs and engineers its own hardware, software, and clinical protocols in-house, powering a next-generation health scan delivered across clinics in Sweden, the UK, and now the United States. SOURCE Neko Health Published by News Desk · WeeklyReviewer The WeeklyReviewer news desk monitors breaking developments around the clock - sourcing, verifying, and publishing real-time industry news across business, technology, politics, science, sports, and world affairs. Every story that comes through the Live Wire is reviewed for accuracy before publication, keeping our readers ahead of the curve without the noise.

Fortune
Sep 24th, 2026
A $499 checkup gave me a peek at the future of AI-powered health care.

A $499 checkup gave me a peek at the future of AI-powered health care. * In today's CEO Daily: Can AI make health care better - and cheaper? * The big leadership story: Travis Kalanick's return to Silicon Valley * The markets: Surging Treasury yields spark a selloff. * Plus: All the news and watercooler chat from Fortune. Good morning. Earlier this week, I got an AI-powered physical exam that frankly wowed me, from a scan that mapped my skin and body composition to heart, blood, and metabolic health tests. A physician walked me through the results a few minutes later while standing in front of my 3D image in a room more reminiscent of "2001: A Space Odyssey" than my doctor's office. Neko Health, a Swedish health care and technology company founded by Spotify's Daniel Ek and CEO Hjalmar Nilsonne, opened its first U.S. clinic in Manhattan yesterday, offering this package for $499. It was the kind of health care experience I've always wanted and rarely received: fast, simple, and proactive. "We want to create this almost magical consumer experience around health care," Nilsonne told me. "We want to democratize high-quality preventive health care and make it available to millions or hundreds of millions of people." There's a lot of discussion about health right now: the health of the planet, the health of our economies, and, of course, the health of our own bodies. We are living longer at a time when health care is getting more expensive, jobs are becoming less secure and much of the developed world is bracing for a 'silver tsunami' as aging populations impact everything from tax revenue to consumer behavior. The Trump administration announced plans this week to remove 760,000 Affordable Care Act enrollees from public health care exchanges as part of a crackdown on fraud. The problems are profound, but I'm also struck by the promise of what's happening right now, via AI and beyond: The desire to disrupt. There are now thousands of AI-powered health care startups and plenty of disruption within the system, too. AI is saving at least 132 hours annually for half of the health care professionals surveyed in the 2026 Philips Future Health Index. They report seeing more patients and making fewer mistakes. But the most critical disruption for many Americans is cost. I spoke with Mark Cuban at the Digital Health New York Summit last week about how he's disrupting pharmacy benefit managers (PBMs) with Cost Plus Drugs. Launched in early 2022, the direct-to-patient pharmacy business has expanded to manufacturing, where, Cuban says, volume has increased enough to lower the price of 190 medications. He said the company is making money, thanks in part to demand generated by TrumpRx, but that's not the goal. "My mission is just to fuck up health care," he said. "Trying to optimize a broken system doesn't really change anything." The desire to live better. Bryan Johnson might want to live forever - and this 55-year-old single mother is aging at a slower pace - but most of us just want to be healthier in the time that we're here. Is America getting healthier? When it comes to obesity and death from cancer, yes. When it comes to managing stress and the ability to afford health care, no. So it matters that companies like Walmart are trying to put more emphasis on nutrition and initiatives like its Health Ambassador pilot to make health care more accessible. Most important, though, is our growing understanding of the systemic nature of health. I spoke this week with Frederick Lowery, who became CEO of Henry Schein in March. As leader of the world's largest distributor of dental equipment, supplies, and services, he's eager to explore the links between oral health and a range of chronic ailments. The desire to engage. Large U.S. employers expect a median 9.2% increase in health care costs next year, according to the nonprofit Business Group on Health. About half expect to push those costs onto workers, a record number of whom are already disengaged. But Whole Foods CEO Jason Buechel, who also oversees all of Amazon grocery, has a different approach. He came in earlier this week to talk about how the company is investing in organic foods and in workers through higher pay, apprenticeship programs, and cheap health care. There's been a lot of attention to the decision to raise the hourly pay of 100,000 workers to $21 an hour. But Buechel hopes the introduction of low-cost health care and apprenticeship programs could turn what is typically a high-turnover job into a compelling career. I suspect one reason Amazon can do that is that it's also creating AI-powered health care offerings for consumers. While health care spending is expected to hit $6 trillion this year, the opportunities to create cheaper and better solutions may grow faster. Contact CEO Daily via Diane Brady at [email protected] Top leadership news. Travis Kalanick's return to Silicon Valley Nearly a decade after Uber forced him out, Travis Kalanick is back with Atoms, a robotics and food-delivery startup with $1.7 billion in backing. His return comes as some investors and younger founders have embraced a more founder-driven view of Silicon Valley. Meta gets an early lead in AI glasses Meta has sold smart glasses at a growing clip, with partner EssilorLuxottica reporting 7 million pairs sold in 2025, giving the company an early lead in a race to build post-smartphone AI hardware. The glasses' appeal and Meta's advantage come with a major caveat: cameras and AI features that see and hear the world around users have sharpened privacy concerns. Why a diesel-export ban could backfire President Donald Trump has backed calls for a temporary ban on diesel exports as U.S. diesel prices hit a record $6.52 a gallon. Oil-industry analysts say the move could initially curb prices in some places but ultimately force refineries to cut output, raise gasoline and jet fuel prices, and worsen a global diesel shortage. The markets. S&P 500 futures are down 0.60% this morning. The last session closed down 0.75%. The STOXX Europe 600 was down 0.54% in early trading. The U.K.'s FTSE 100 was down 0.06% in early trading. Japan's Nikkei 225 was up 0.76%. South Korea's markets are closed today. China's CSI 300 was down 1.73%. Hong Kong's Hang Seng was down 0.29%. India's NIFTY 50 was down 1.46%. Bitcoin is down at $83k.

Longevity.Technology
Sep 9th, 2026
Neko Health body scan lands in NYC with 25K on the waitlist.

Neko Health body scan lands in NYC with 25K on the waitlist. Prevention gets tech budget it deserves as a $499, hour-long body scan backed by Zuckerberg and Sharapova lands in SoHo. There's a line that Neko Health likes to point to: 25,000 New Yorkers signed up before the company had even picked a paint color for its walls. It's a waitlist number for a clinic that hadn't opened yet, in a city that already has some of the best hospitals on the planet. So why the line? Because Neko is selling the hour before anything goes wrong. Strip away the marketing language and the Neko Health Scan is fairly simple to describe: one visit, about 60 minutes, no needles that draw blood in the traditional sense, no radiation. The machine and the clinician together gather a broad range of information about your heart, your skin, your blood chemistry, your metabolic markers - then you sit down with an actual person who walks you through what it means and what, if anything, you should do next [1]. That last part is the part longevity researchers have been begging for. Most of Longevity Ltd. don't get a full-body check until something already hurts. Neko is betting that people will pay to find problems before they have symptoms, and the early numbers back that bet up: more than 350,000 people worldwide have joined the waitlist or already booked a scan, and in the UK and Sweden, over 100,000 have actually gone through with it. Three out of four of those people liked what they got enough to prepay for the next one. Neko Health co-founder and CEO Hjalmar Nilsonne framed the US launch as a question the company had been sitting with for years. "We've spent the last few years asking a simple question: What if a single visit could give you a more complete picture of your health, where it's heading, and a clear plan from a medical professional to change what happens next?" he said. "New York felt like the right place to bring that idea to the US It's a city where people are used to having access to the best of everything - and we think healthcare should be no different." The SoHo location, opening 24 September at 300 Lafayette Street, isn't a converted storefront with a folding table and a blood pressure cuff. It's a two-floor buildout with seven scan rooms, built to look and feel less like a doctor's office and more like the kind of space you'd actually want to return to. That's deliberate. Preventive care only works if people show up more than once, and Neko is designing for the second visit as much as the first. None of this comes cheap to build. Neko's US push follows a $700 million Series C, led by Lightspeed Venture Partners and co-led by OG Venture Partners. The investor list reads like a longevity dinner party: Mark Zuckerberg and Priscilla Chan, tennis great Maria Sharapova, Tim Ferriss, will.i.am, restaurateur Danny Meyer. When people with that much money and that much choice about where to put it all land on the same preventive health company, it says something about where the smart capital thinks health care is headed. New York is just the opening chapter. Neko plans additional NYC locations, then Miami, then Washington DC and San Francisco, all within the next year. The longevity angle nobody should skip. Here's the part that matters most for anyone thinking about healthy aging: most of the diseases that shorten its lives don't announce themselves early. Heart disease, metabolic decline, some cancers - they build quietly for years before symptoms show up, and by then, the cheapest and easiest window to intervene has often closed. A yearly, deep-dive body scan doesn't replace your doctor. But it does something longevity science has been pushing for over a decade: it moves the moment of discovery earlier, when there's still time to actually change the trajectory. That's the real product Neko is selling. Not a scan, but time.